"Východoslovenský onkologický ústav Košice vznikol 1.7.2003 a dňa 20.2.2006 sa transformoval na akciovú spoločnosť s názvom Východoslovenský onkologický ústav, a.s.. Jeho poslaním je predovšetkým poskytovať komplexnú ambulantnú a ústavnú zdravotnú starostlivosť pacientom s onkologickým ochorením – diagnostika, liečba a dispenzárna starostlivosť o onkologických pacientov. V ústavnej starostlivosti zabezpečuje onkologickú, onko-otorinolaryngologickú, onko-gynekologickú starostlivosť, komplexnú protinádorovú liečbu – radiačnú a chemoterapeutickú liečbu. Okrem iného zabezpečuje teoretickú i praktickú časť výučby žiakov stredných zdravotníckych škôl, teoretickú i praktickú časť vysokoškolského vzdelávania v zdravotníckych povolaniach."
Top Sponsors
Top Collaborators
Trials By Phase
Recruitment Status
Top Conditions
Intervention Types
Top Intervention Names
Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
7
Pfizer
7
Arcus Biosciences, Inc.
1
Ferring Pharmaceuticals
1
Janssen Pharmaceutica N.V., Belgium
1
Jounce Therapeutics, Inc.
1
Smartfish AS
1
Clinical Trials at Vychodoslovensky onkologicky ustav, a.s.
During the past decade, Vychodoslovensky onkologicky ustav, a.s. conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 9 clinical trials were completed, i.e. on
average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 2 clinical trials were completed. i.e. 25%
of trials that started reached the finish line.
A Study to Compare Subcutaneous (SC) Versus Intravenous (IV) Administration of Herceptin (Trastuzumab) in Women With Human Epidermal Growth Factor Receptor (HER) 2-Positive Early Breast Cancer
A Safety and Tolerability Study of Assisted and Self-Administered Subcutaneous (SC) Herceptin (Trastuzumab) as Adjuvant Therapy in Early Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer
An Extension Study to Provide Continued Bevacizumab Therapy to Participants With Solid Tumors Who Were Previously Enrolled in a Roche/Genentech Sponsored Study
Pilot Study of Safety and Tolerability of Nutrifriend Cachexia in NSCLC Cachexia
2015-07-01
2017-05-01
Completed
56
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Vychodoslovensky onkologicky ustav, a.s." #1 sponsor was "Hoffmann-La Roche" with 7 trials, followed by "Pfizer" with 7 trials
sponsored, "Arcus Biosciences, Inc." with 1 trials sponsored, "Ferring Pharmaceuticals" with 1 trials sponsored and "Janssen Pharmaceutica N.V., Belgium"
with 1 trials sponsored. Other sponsors include -3 different institutions and
companies that sponsored additional 7 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Vychodoslovensky onkologicky ustav, a.s."
#1 collaborator was "Astellas Pharma Inc" with 3 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "Medivation LLC, a wholly owned subsidiary of Pfizer Inc." with 2 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator and "Duke Clinical Research Institute" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 9 trials.
Clinical Trials Conditions at Vychodoslovensky onkologicky ustav, a.s.
According to Clinical.Site data, the most researched conditions in "Vychodoslovensky onkologicky ustav, a.s." are
"Prostate Cancer" (4 trials), "Cancer of the Prostate" (2 trials), "Early Breast Cancer" (2 trials), "NSCLC" (2 trials) and "Neoplasms" (2 trials). Many other conditions were trialed in "Vychodoslovensky onkologicky ustav, a.s." in a lesser frequency.
Clinical Trials Intervention Types at Vychodoslovensky onkologicky ustav, a.s.
Most popular intervention types in "Vychodoslovensky onkologicky ustav, a.s." are "Drug" (18 trials), "Biological" (2 trials), "Dietary Supplement" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "Bevacizumab" (3 trials), "Docetaxel" (3 trials), "Pemetrexed" (3 trials), "Cetuximab" (2 trials) and "Encorafenib" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Vychodoslovensky onkologicky ustav, a.s.
The vast majority of trials in "Vychodoslovensky onkologicky ustav, a.s." are
11 trials for "All" genders, 5 trials for "Male" genders and 3 trials for "Female" genders.
Clinical Trials Status at Vychodoslovensky onkologicky ustav, a.s.
Currently, there are NaN active trials in "Vychodoslovensky onkologicky ustav, a.s.".
undefined are not yet recruiting,
6 are recruiting,
4 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 7 completed trials in Vychodoslovensky onkologicky ustav, a.s.,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Vychodoslovensky onkologicky ustav, a.s., 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 15 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 1 trials that are defined as “Not Applicable".
Departments of Vychodoslovensky onkologicky ustav, a.s.
Vychodoslovensky onkologicky ustav, a.s. has several departments that took part in Clinical trials: "Vychodoslovensky onkologicky ustav Oddelenie klinickej onkologie" - 2 trials